Back to ACAD
TRUIST FINANCIAL CORP ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
15
Latest value
$3.9M
Q3 2026
Peak value
$3.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $550K |
| Q3 2025 | $130K |
| Q3 2025 | $2M |
| Q4 2025 | $797K |
| Q4 2025 | $131K |
| Q4 2025 | $2M |
| Q1 2026 | $589K |
| Q1 2026 | $1.7M |
| Q1 2026 | $42K |
| Q2 2026 | $749K |
| Q2 2026 | $1.9M |
| Q2 2026 | $38K |
| Q3 2026 | $606K |
| Q3 2026 | $38K |
| Q3 2026 | $3.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.9M | 22.2K | — | — |
| Q3 2026 | $38K | 216 | — | — |
| Q3 2026 | $606K | 30.1K | — | — |
| Q2 2026 | $38K | 216 | — | — |
| Q2 2026 | $1.9M | 10.7K | — | — |
| Q2 2026 | $749K | 29.6K | — | — |
| Q1 2026 | $42K | 253 | — | — |
| Q1 2026 | $1.7M | 10.4K | — | — |
| Q1 2026 | $589K | 26.5K | — | — |
| Q4 2025 | $2M | 11.1K | — | — |
| Q4 2025 | $131K | 731 | — | — |
| Q4 2025 | $797K | 29.8K | — | — |
| Q3 2025 | $2M | 11.1K | — | — |
| Q3 2025 | $130K | 736 | — | — |
| Q3 2025 | $550K | 25.8K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M